Report #2824133

Received Feb 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: NJ
Recovered: Unknown
Vaccinated: Jan 7, 2025
Onset: Jan 7, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEPA	HEP A (HAVRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	55M72	—

Symptoms (1)

Expired product administered

Symptom narrative

received an expired dose of Havrix; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a 22-year-old female patient who received HAV (Havrix) (batch number 55M72, expiry date 13-DEC-2024) for prophylaxis. On 07-JAN-2025, the patient received the 1st dose of Havrix. On 07-JAN-2025, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: received an expired dose of Havrix). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-JAN-2025 Reporter explained that a patient received an expired dose of Havrix on January 7th 2025 and vaccine was expired on December 13th 2024 which led to expired vaccine used. It was the first dose of a Hepatitis A vaccine for the patient.